GSK.L
Price:
$1419.5
Market Cap:
$57.90B
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in we...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1988-07-01
Stock Exchange
LSE
Ticker
GSK.L
According to GSK plc’s latest financial reports and current stock price. The company's current Enterprise Value is 70.77B. This represents a change of -7.95% compared to the average of 76.88B of the last 4 quarters.
The mean historical Enterprise Value of GSK plc over the last ten years is 74.70B. The current 70.77B Enterprise Value has changed 9.37% with respect to the historical average. Over the past ten years (40 quarters), GSK.L's Enterprise Value was at its highest in in the September 2019 quarter at 98.54B. The Enterprise Value was at its lowest in in the September 2015 quarter at 60.08B.
Average
74.70B
Median
74.33B
Minimum
64.40B
Maximum
96.92B
Discovering the peaks and valleys of GSK plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 24.33%
Maximum Annual Enterprise Value = 96.92B
Minimum Annual Increase = -22.80%
Minimum Annual Enterprise Value = 64.40B
Year | Enterprise Value | Change |
---|---|---|
2023 | 73.84B | -1.73% |
2022 | 75.14B | 4.56% |
2021 | 71.87B | -3.94% |
2020 | 74.82B | -22.80% |
2019 | 96.92B | 19.06% |
2018 | 81.40B | 24.33% |
2017 | 65.47B | -12.98% |
2016 | 75.23B | 16.82% |
2015 | 64.40B | -5.16% |
2014 | 67.91B | -10.20% |
The current Enterprise Value of GSK plc (GSK.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
73.62B
5-year avg
78.52B
10-year avg
74.70B
GSK plc’s Enterprise Value is less than AstraZeneca PLC (247.52B), less than BP p.l.c. (108.68B), less than Unilever PLC (167.17B), greater than Vodafone Group Public Limited Company (70.68B), less than National Grid plc (94.75B),
Company | Enterprise Value | Market cap |
---|---|---|
247.52B | $170.87B | |
108.68B | $60.25B | |
167.17B | $117.79B | |
70.68B | $18.87B | |
94.75B | $48.23B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GSK plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GSK plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is GSK plc's Enterprise Value?
What is the highest Enterprise Value for GSK plc (GSK.L)?
What is the 3-year average Enterprise Value for GSK plc (GSK.L)?
What is the 5-year average Enterprise Value for GSK plc (GSK.L)?
How does the current Enterprise Value for GSK plc (GSK.L) compare to its historical average?